Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer

Table 1 Clinical symptoms, laboratory findings, and computed tomography findings

	XGC(n = 6)	GB carcinoma (n = 16)	P value
Age (mean ± SD, yr)	64.3 ± 9.7	67.9 ± 12.0	0.5148
Gender			0.8558
Male	4	8
Female	2	8
Abdominal pain			0.4806
Presence	4	8
Absence	2	8
Fever			0.4726
Yes	1	1
No	5	15
Jaundice			0.6707
Yes	1	4
No	5	12
Albumin (mean ± SD, mg/dL)	3.8 ± 0.4	3.8 ± 0.3	0.8090
Neutrophil/lymphocyte ratio (mean ± SD)	2.1 ± 0.9	2.4 ± 1.0	0.6280
CEA (mean ± SD)	1.9 ± 0.6	3.1 ± 3.5	0.2205
CA19-9 (mean ± SD)	232.7 ± 488.5	354.0 ± 737.1	0.6806
Cholecystolithiasis			0.0116
Yes	5	4
No	1	12
Diffuse gallbladder wall thickening (CT findings)			0.1551
Yes	3	3
No	3	13
Continuous mucosal line (CT findings)			0.0616
Yes	3	2
No	3	14
Intramural hypoattenuated nodule			0.0024
Yes	3	1
No	3	15
Bile duct dilatation			0.9035
Yes	1	3
No	5	13

XGC: Xanthogranulomatous cholecystitis; GB: Gall bladder; CT: Computed tomography.